))
How Kite Pharma Is Revolutionizing the Fight Against Cancer
Archived series ("Inactive feed" status)
When?
This feed was archived on May 11, 2018 01:28 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 181944461 series 1276218
Content provided by Zacks Investment Research. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Zacks Investment Research or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Immunotherapy is a hot corner of the biotech world. Learn how companies in this sector fight cancer in this podcast which features Dr. David Chang, the Chief Medical Officer of Kite Pharma. Do not miss it! Please pick a time stamped topic below:
(0:55) - The Role of a Chief Medical Officer at a Biotech Company
(2:25) - Why is the ASCO conference Important To Kite Pharma?
(4:15) - Kite's Approach to Cellular Therapy: How a 'T Cell Receptor' and a 'Chimeric Antigen Receptor' Help Fight Cancer
(7:00) - What Cancers Are These Therapies Most Effective In Treating?
(8:40) - Why Is Immunotherapy On The Rise and What Are The Risks?
(11:05) - What Have Been The Results For These Therapies?
(13:20) - What's The Future For Cellular Therapy?
(15:30) - Episode Roundup: Podcast@Zacks.com
46 episodes
Share
